ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Effects of enoxaparin and aspirin on metastatic spread in a murine melanoma model.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeAnticoagulation/ antiplatelet treatment could potentially reduce the metastatic process, however, consistent evidence is lacking. Here we explored an in vivo model of experimental metastasis of murine B16 melanoma to observe tumor cell extravasation under therapy with aspirin or enoxaparin.
methodsThree treatment groups by 5 C57BL/6 female mice were injected with B16/F10 cells in the retro orbital sinus. After two weeks necropsy was performed.
resultsIn the group treated with enoxaparin, a marked reduction in the number of metastatic foci in the lungs, with 6-193 metastases and 0.04-2.3% affected lung area were observed. The control group had 561-1000 metastatic lesions and 13-21% affected area. In the aspirin-treated group, there was a reduction in the number of metastatic lesions (386 - 640) and area (6.4-19%).
conclusionsBoth aspirin and enoxaparin treatment affect the progression of metastases in mice, with enoxaparin being the most effective.
Indexed as
Identifiers
41533297What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.